Androgen Regulation of micro-RNAs in Prostate Cancer

被引:120
作者
Waltering, Kati K. [1 ,2 ]
Porkka, Kati P. [1 ,2 ]
Jalava, Sanni E. [1 ,2 ]
Urbanucci, Alfonso [1 ,2 ]
Kohonen, Pekka J. [3 ]
Latonen, Leena M. [1 ,2 ]
Kallioniemi, Olli P. [3 ,4 ]
Jenster, Guido [5 ]
Visakorpi, Tapio [1 ,2 ]
机构
[1] Univ Tampere, Inst Med Technol, FIN-33014 Tampere, Finland
[2] Tampere Univ Hosp, Tampere, Finland
[3] VTT Tech Res Ctr Finland, Turku, Finland
[4] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland
[5] Erasmus Univ, Dept Urol, Josephine Nefkens Inst, Med Ctr, NL-3000 DR Rotterdam, Netherlands
基金
芬兰科学院;
关键词
AR; prostatic carcinoma; neoplasia; hormone-refractory; LNCaP-ARhi; MIR-200; FAMILY; RECEPTOR GENE; EXPRESSION; PROGRESSION; CARCINOMA; STEROIDOGENESIS; DIFFERENTIATION; OVEREXPRESSION; TRANSFORMATION; AMPLIFICATION;
D O I
10.1002/pros.21276
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. Androgens play a critical role in the growth of both androgen dependent and castration-resistant prostate cancer (CRPC). Only a few micro-RNAs (miRNAs) have been suggested to be androgen regulated. We aim to identify androgen regulated miRNAs. METHODS. We utilized LNCaP derived model, we have established, and which over-expresses the androgen receptor (AR), the VCaP cell line, and 13 intact-castrated prostate cancer (PC) xenograft pairs, as well as clinical specimens of untreated (PC) and CRPC. The expression of miRNAs was analyzed by microarrays and quantitative RT-PCR (Q-RT-PCR). Transfection of pre-miR-141 and anti-miR-141 was also used. RESULTS. Seventeen miRNAs were > 1.5-fold up-or downregulated upon dihydrotestosterone (DHT) treatment in the cell lines, and 42 after castration in the AR-positive xenografts. Only four miRNAs (miR-10a, miR-141, miR-150*, and miR-1225-5p) showed similar androgen regulation in both cell lines and xenografts. Of those, miR-141 was found to be expressed more in PC and CRPC compared to benign prostate hyperplasia. Additionally, the overexpression of miR-141 enhanced growth of parental LNCaP cells while inhibition of miR-141 by anti-miR-141 suppressed the growth of the LNCaP subline overexpressing AR. CONCLUSIONS. Only a few miRNAs were found to be androgen-regulated in both cell lines and xenografts models. Of those, the expression of miR-141 was upregulated in cancer. The ectopic overexpression of miR-141 increased growth of LNCaP cell suggesting it may contribute to the progression of PC. Prostate 71: 604-614, 2011. (C) 2010 Wiley-Liss, Inc.
引用
收藏
页码:604 / 614
页数:11
相关论文
共 47 条
  • [31] miR-21: An Androgen Receptor-Regulated MicroRNA that Promotes Hormone-Dependent and Hormone-Independent Prostate Cancer Growth
    Ribas, Judit
    Ni, Xiaohua
    Haffner, Michael
    Wentzel, Erik A.
    Salmasi, Amirali Hassanzadeh
    Chowdhury, Wasim H.
    Kudrolli, Tarana A.
    Yegnasubramanian, Srinivasan
    Luo, Jun
    Rodriguez, Ron
    Mendell, Joshua T.
    Lupold, Shawn E.
    [J]. CANCER RESEARCH, 2009, 69 (18) : 7165 - 7169
  • [32] MicroRNAs accurately identify cancer tissue origin
    Rosenfeld, Nitzan
    Aharonov, Ranit
    Meiri, Eti
    Rosenwald, Shai
    Spector, Yael
    Zepeniuk, Merav
    Benjamin, Hila
    Shabes, Norberto
    Tabak, Sarit
    Levy, Asaf
    Lebanony, Danit
    Goren, Yaron
    Silberschein, Erez
    Targan, Nurit
    Ben-Ari, Alex
    Gilad, Shlomit
    Sion-Vardy, Netta
    Tobar, Ana
    Feinmesser, Meora
    Kharenko, Oleg
    Nativ, Ofer
    Nass, Dvora
    Perelman, Marina
    Yosepovich, Ady
    Shalmon, Bruria
    Polak-Charcon, Sylvie
    Fridman, Eddie
    Avniel, Amir
    Bentwich, Isaac
    Bentwich, Zvi
    Cohen, Dalia
    Chajut, Ayelet
    Barshack, Iris
    [J]. NATURE BIOTECHNOLOGY, 2008, 26 (04) : 462 - 469
  • [33] TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis
    Saramaki, Outi R.
    Harjula, Anna E.
    Martikainen, Paula M.
    Vessella, Robert L.
    Tammela, Teuvo L. J.
    Visakorpi, Tapio
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (11) : 3395 - 3400
  • [34] Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma
    Schaefer, Annika
    Jung, Monika
    Mollenkopf, Hans-Joachim
    Wagner, Ina
    Stephan, Carsten
    Jentzmik, Florian
    Miller, Kurt
    Lein, Michael
    Kristiansen, Glen
    Jung, Klaus
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (05) : 1166 - 1176
  • [35] An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells
    Shi, Xu-Bao
    Xue, Lingru
    Yang, Joy
    Ma, Ai-Hong
    Zhao, Jianjun
    Xu, Ma
    Tepper, Clifford G.
    Evans, Christopher P.
    Kung, Hsing-Jien
    White, Ralph W. deVere
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (50) : 19983 - 19988
  • [36] The Role of microRNA-221 and microRNA-222 in Androgen-Independent Prostate Cancer Cell Lines
    Sun, Tong
    Wang, Qianben
    Balk, Steven
    Brown, Myles
    Lee, Gwo-Shu Mary
    Kantoff, Philip
    [J]. CANCER RESEARCH, 2009, 69 (08) : 3356 - 3363
  • [37] The MicroRNA Profile of Prostate Carcinoma Obtained by Deep Sequencing
    Szczyrba, Jaroslaw
    Loeprich, Elke
    Wach, Sven
    Jung, Volker
    Unteregger, Gerhard
    Barth, Stephanie
    Grobholz, Rainer
    Wieland, Wolf
    Stoehr, Robert
    Hartmann, Arndt
    Wullich, Bernd
    Graesser, Friedrich
    [J]. MOLECULAR CANCER RESEARCH, 2010, 8 (04) : 529 - 538
  • [38] Androgen receptor mutations in androgen-in dependent prostate cancer: Cancer and Leukemia Group B Study 9663
    Taplin, ME
    Rajeshkumar, B
    Halabi, S
    Werner, CP
    Woda, BA
    Picus, J
    Stadler, W
    Hayes, DF
    Kantoff, PW
    Vogelzang, NJ
    Small, EJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (14) : 2673 - 2678
  • [39] Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
    Tomlins, SA
    Rhodes, DR
    Perner, S
    Dhanasekaran, SM
    Mehra, R
    Sun, XW
    Varambally, S
    Cao, XH
    Tchinda, J
    Kuefer, R
    Lee, C
    Montie, JE
    Shah, RB
    Pienta, KJ
    Rubin, MA
    Chinnaiyan, AM
    [J]. SCIENCE, 2005, 310 (5748) : 644 - 648
  • [40] van Weerden WM, 2000, PROSTATE, V43, P263